Families battle insurance over world’s most expensive drug
02:28
The drug, Zolgensma, is a life-saving, single-dose gene therapy that treats children with spinal muscular atrophy or SMA, a disease that takes away the ability to walk, breathe and eat. Two months after the FDA approved it, families across the country say they’re being denied access to the drug because insurance refuses to pay.July 26, 2019
UP NEXT
Phoenix-area third-graders surprised with full college scholarships
02:29
Class of 2022 entering the best job market in years
02:17
Memorial Day travel kicks off
01:29
Georgia’s GOP Primaries to Test Trump’s Influence
02:03
Cities hit record-breaking temps in May heatwave
01:38
Ukrainian President and First Lady appear in rare joint interview